TRIB3 and Insulin resistance: Prior rodent studies [64-66,69], indicate that TRIB3 overexpression plays a major role in modulating whole-body insulin sensitivity and suggest a possible involvement in the pathogenesis of insulin resistance-related metabolic abnormalities.